Terms/Glossary

Skriv ut

News Archive

27 March 2008
Top Management and Board nomination update

13 March 2008
Clavis Pharma announces expansion of ELACYT clinical development program

25 February 2008
Fourth Quarter Report 2008

14 February 2008
Fourth Quarter financial report

11 February 2008
Clavis Pharma successfully completes clinical phase I study in haematology

19 December 2007
Clavis Pharma enters into Market Maker Agreement

15 October 2007
Clavis Pharma Completes its Executive Management Team

20 September 2007
Clavis Pharma Receives European Orphan Drug Designation of ELACYT for the Treatment of Acute Myeloid Leukaemia

17 September 2007
Clavis Pharma Strengthens Senior Management

24 August 2007
Second Quarter Report 2007